MedPath

Thermal radiofrequency ablation of trigeminal nerve for treatment of electric like shooting pain along the distribution of that nerve

Phase 4
Conditions
Health Condition 1: G500- Trigeminal neuralgia
Registration Number
CTRI/2019/03/018165
Lead Sponsor
ESI Institute of Pain Management
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Classical Trigeminal Neuralgia according to ICHD-3 criteria for more than 6 months.

2.Failed medical management. (Optimum medical management tried at least for 3 months, or side effects of medications are unbearable).

3.Pain in Numeric Rating Scale (NRS) score of more than 7/10 with a poor quality of life.

4.No organic disease on brain MRI and MR angiography and no involvement of any artery and vein.

Exclusion Criteria

1.Patient is unwilling to undergo procedure

2.Bleeding disorders

3.Patients on regular anticoagulants

4.Local infection

5.Sepsis

6.Uncontrolled hypertension (Blood pressure > 170/100 mm of Hg)

7.Uncontrolled diabetes mellitus

8.Unstable cardiovascular status

9.Psychiatric disorder

10.Intracranial benign/ malignant space occupying lesion (SOL)

11.Multiple sclerosis

12.Patients previously underwent surgical treatment (microvascular decompression, gamma knife radiosurgery, balloon decompression, other invasive procedures.)

13.Oro-maxillofacial diseases, tumours, congenital malformations.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain in Numeric Rating ScoreTimepoint: Before RF and after 7 days, 1 month, 6 months, 12 months, 36 months of intervention
Secondary Outcome Measures
NameTimeMethod
Analgesic dose requirementTimepoint: Before RF and after 7 days, 1 month, 6 months, 12 months, 36 months of intervention;Baclofen doseTimepoint: Before RF and after 7 days, 1 month, 6 months, 12 months, 36 months of intervention;BNI Pain ScoreTimepoint: Before RF and after 7 days, 1 month, 6 months, 12 months, 36 months of intervention;Carbamazepine doseTimepoint: Before RF and after 7 days, 1 month, 6 months, 12 months, 36 months of intervention;Gabapentin/ Pregabalin doseTimepoint: Before RF and after 7 days, 1 month, 6 months, 12 months, 36 months of intervention;SF 36 Quality of Life ScoreTimepoint: Before RF and after 7 days, 1 month, 6 months, 12 months, 36 months of intervention
© Copyright 2025. All Rights Reserved by MedPath